Skip to main content
. 2022 Nov 29;14(23):5079. doi: 10.3390/nu14235079

Table 1.

Sample characteristics for entire cohort and by treatment allocation at baseline.

Whole Sample Active Placebo
n M SD M SD M SD p
Age 141 52.84 6.87 53.02 6.78 52.67 7.01 0.763
MMSE 141 29.31 0.95 29.30 0.97 29.34 0.94 0.813
Education years 141 16.94 3.36 17.23 3.75 16.66 2.93 0.319
BMI 141 27.26 5.22 28.19 5.59 26.35 4.67 0.036 *
Waist Circumference 140 95.91 14.77 97.97 15.74 93.85 13.54 0.099
Hip Circumference 140 107.21 9.15 105.35 10.03 106.06 8.08 0.139
BDI 141 4.00 4.37 3.97 4.40 4.03 4.36 0.939
Diet quality 141 62.10 13.00 60.40 12 63.77 13.31 0.124
NART 141 37.13 5.38 36.79 5.60 37.45 5.17 0.465
STAI-trait 141 31.48 7.42 31.43 7.65 31.54 7.25 0.932
Brachial systolic 141 119.28 12.36 120.30 12.67 118.28 12.05 0.334
Brachial diastolic 141 73.92 8.47 73.84 9.08 74.00 7.90 0.913
Vitamin B1 94 126.60 33.80 126.22 36.85 127.00 30.56 0.912
Vitamin B2 135 233.36 42.70 233.91 38.68 232.79 46.82 0.879
RBC Folate 62 1242.50 1285.15 152.06 1211.69 314.75 0.464
Vitamin B6 139 116.85 118.54 114.06 108.10 119.60 128.73 0.833
Vitamin B12 139 321.09 114.11 329.33 99.74 312.96 126.89 0.271
Homocysteine 139 10.28 2.84 9.82 2.55 10.73 3.05 0.062
High-sensitivity C-reactive protein 135 1.77 2.98 2.12 3.56 1.43 2.28 0.180

Variables were compared across active treatment and placebo groups using t-tests. * p < 0.05.